Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes

Imagem de Miniatura
Arquivos
art_FREIRE_CarbapenemResistant_Enterobacteriaceae_Acquired_Before_Liver_Transplantation_Impact_on_2017.PDF (410.91 KB)
Citações na Scopus
55
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
CAMARGO, Carlos H.
Citação
TRANSPLANTATION, v.101, n.4, p.811-820, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background. Carbapenem-resistant Enterobacteriaceae (CRE) is an emergent microorganism of infections after liver transplant (LT). The aim of this study was to analyze the risk factors for CRE acquisition and infection after LT. Methods. This was a prospective cohort study involving patients who underwent LT in the 2010 to 2014 period. Surveillance cultures for CRE were collected immediately before LT and weekly thereafter until hospital discharge. Results. We analyzed 386 patients undergoing a total of 407 LTs. Before LT, 68 (17.6%) patients tested positive for CRE, 11 (16.2%) of those patients having CRE infection, whereas 119 (30.8%) patients acquired CRE after LT. Post-LT CRE infection was identified in 59 (15.7%) patients: Klebsiella pneumoniae was isolated in 83.2%; surgical site infection was the most common type of infection (46.7%). Multivariate analysis showed that post-LT dialysis was the only risk factor for post-LT CRE acquisition. Eighty-two percent of patients who underwent 3 or more post-LT dialysis sessions and acquired CRE before LT evolved with post-LT CRE infection. Other risk factors for CRE infection were acquisition of CRE post-LT, Model for End-Stage Liver Disease score greater than 32, combined transplantation, and reoperation. Patients who acquired CRE before LT had a high risk of developing CRE infection (P < 0.001). Conclusions. Measures for minimizing that risk, including altering the antibiotic prophylaxis, should be investigated and implemented.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/20065
Referências
  1. Bellier C, 2008, TRANSPL INT, V21, P755, DOI 10.1111/j.1432-2277.2008.00673.x
  2. Bert F, 2014, TRANSPL INFECT DIS, V16, P84, DOI 10.1111/tid.12169
  3. Bodro M, 2013, TRANSPLANTATION, V96, P843, DOI 10.1097/TP.0b013e3182a049fd
  4. Bogan C, 2014, AM J INFECT CONTROL, V42, P612, DOI 10.1016/j.ajic.2014.02.013
  5. Centers for Disease Control, CDC NHSN SURV DEF SP
  6. Clancy CJ, 2013, AM J TRANSPLANT, V13, P2619, DOI 10.1111/ajt.12424
  7. de Oliveira MS, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.07.010
  8. Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af
  9. Freire MP, 2015, INFECTION, V43, P315, DOI 10.1007/s15010-015-0743-4
  10. Freire MP, 2016, LIVER TRANSPLANT, V22, P615, DOI 10.1002/lt.24389
  11. Prado MEG, 2008, TRANSPLANTATION, V85, P1849, DOI 10.1097/TP.0b013e3181735407
  12. Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977
  13. Giannella M, 2015, AM J TRANSPLANT, V15, P1708, DOI 10.1111/ajt.13136
  14. Gyung Y, 2005, MICROB DRUG RESIST, V11, P165
  15. Kalpoe JS, 2012, LIVER TRANSPLANT, V18, P468, DOI 10.1002/lt.23374
  16. Kim YJ, 2014, TRANSPL P, V46, P828, DOI 10.1016/j.transproceed.2013.11.030
  17. Lubbert C, 2014, INFECTION, V42, P309, DOI 10.1007/s15010-013-0547-3
  18. Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7
  19. Pereira MR, 2015, LIVER TRANSPLANT, V21, P1511, DOI 10.1002/lt.24207
  20. PulseNet/CDC, PATH PROT
  21. Satlin MJ, 2014, CLIN INFECT DIS, V58, P1274, DOI 10.1093/cid/ciu052
  22. Shi SH, 2009, TRANSPL INFECT DIS, V11, P405, DOI 10.1111/j.1399-3062.2009.00421.x
  23. Singh N, 2001, LIVER TRANSPLANT, V7, P100, DOI 10.1053/jlts.2001.21304
  24. Tumbarello M, 2015, J ANTIMICROB CHEMOTH, V70, P2133, DOI 10.1093/jac/dkv086
  25. van Duin D, 2013, AM J TRANSPLANT, V13, P31, DOI 10.1111/ajt.12096
  26. Ye QF, 2014, TRANSPL INFECT DIS, V16, P767, DOI 10.1111/tid.12278
  27. Zhong L, 2012, J INFECTION, V64, P299, DOI 10.1016/j.jinf.2011.12.005
  28. [Anonymous], 2012, M100S22 I CLIN LAB S, V32

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/37
Carregar mais